Winmill & CO. Inc. Buys Shares of 65,350 Nutex Health Inc. $NUTX

Key Points

• Winmill & CO. Inc. acquired 65,350 Nutex Health shares worth approximately $11.2 million, representing about 0.95% of the company and 2.5% of Winmill’s portfolio. Other institutional investors, including BlackRock and Millennium Management, also increased or initiated positions.
• Nutex Health reported quarterly EPS of $9.38, beating the $4.95 consensus estimate, while revenue reached $210.75 million. The company posted a 21.25% net margin and 39.74% return on equity.
• Analyst sentiment remains positive, with a consensus “Moderate Buy” rating and an average target price of $268.33, versus a reported share price of $185.84.

Winmill & CO. Inc. acquired a new position in Nutex Health Inc. (NASDAQ:NUTX - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 65,350 shares of the company's stock, valued at approximately $11,168,000. Nutex Health accounts for 2.5% of Winmill & CO. Inc.'s investment portfolio, making the stock its 17th largest position. Winmill & CO. Inc. owned about 0.95% of Nutex Health at the end of the most recent reporting period.

Several other large investors also recently added to or reduced their stakes in NUTX. BlackRock Inc. bought a new position in Nutex Health in the second quarter worth approximately $69,612,000. Pertento Partners LLP grew its position in shares of Nutex Health by 20.0% during the 4th quarter. Pertento Partners LLP now owns 324,422 shares of the company's stock valued at $53,406,000 after acquiring an additional 54,001 shares during the period. Topline Capital Management LLC increased its stake in shares of Nutex Health by 72.0% in the 2nd quarter. Topline Capital Management LLC now owns 309,131 shares of the company's stock worth $38,484,000 after purchasing an additional 129,418 shares in the last quarter. Vanguard Group Inc. increased its stake in shares of Nutex Health by 12.7% in the 3rd quarter. Vanguard Group Inc. now owns 214,954 shares of the company's stock worth $22,209,000 after purchasing an additional 24,275 shares in the last quarter. Finally, Millennium Management LLC raised its holdings in Nutex Health by 191.1% in the 3rd quarter. Millennium Management LLC now owns 93,396 shares of the company's stock worth $9,650,000 after purchasing an additional 61,308 shares during the period. 5.32% of the stock is currently owned by institutional investors.

Nutex Health Stock Performance

Shares of Nutex Health stock opened at $185.84 on Monday. The company has a market capitalization of $1.27 billion, a P/E ratio of 7.30 and a beta of 0.24. The company has a debt-to-equity ratio of 0.59, a quick ratio of 4.96 and a current ratio of 5.00. The company has a fifty day moving average of $167.30 and a 200 day moving average of $131.25. Nutex Health Inc. has a fifty-two week low of $77.21 and a fifty-two week high of $204.00.

Nutex Health (NASDAQ:NUTX - Get Free Report) last posted its quarterly earnings results on Thursday, August 6th. The company reported $9.38 EPS for the quarter, beating analysts' consensus estimates of $4.95 by $4.43. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%.The business had revenue of $210.75 million for the quarter, compared to analysts' expectations of $215.03 million. On average, sell-side analysts anticipate that Nutex Health Inc. will post 30.11 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms recently weighed in on NUTX. Lake Street Capital reiterated a "buy" rating and set a $310.00 target price (up from $235.00) on shares of Nutex Health in a research report on Tuesday, August 11th. B. Riley Financial began coverage on Nutex Health in a research note on Friday, June 26th. They issued a "buy" rating and a $290.00 price objective on the stock. Weiss Ratings raised Nutex Health from a "hold (c)" rating to a "hold (c+)" rating in a research report on Tuesday, July 28th. Wall Street Zen downgraded Nutex Health from a "strong-buy" rating to a "buy" rating in a research note on Monday, July 20th. Finally, Zacks Research raised shares of Nutex Health to a "hold" rating in a report on Monday, June 29th. Three analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, Nutex Health has a consensus rating of "Moderate Buy" and a consensus target price of $268.33.

Nutex Health Profile

Nutex Health, Inc NASDAQ: NUTX is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source